Abstract
Background
Maternal smoking during pregnancy is associated with adverse outcomes, but its relationship with childhood seizures remains unclear. Previous studies have produced inconsistent findings regarding the link between maternal smoking during pregnancy and seizure risk in offspring. We aim to investigate the association between maternal smoking during pregnancy and seizures in offspring through systematic review and meta-analysis.
Methods
We conducted a search across multiple electronic databases such as PubMed, Embase, ScienceDirect, Scopus, and Web of Science. The search was performed on May 12, 2025. Papers reporting seizure frequency according to maternal smoking or odds ratios for seizure in offspring were selected. Dose-response analysis was performed based on restricted cubic spline analysis between the number of cigarettes per day and the effect estimate. The meta-analysis was performed using Review Manager version 5.4.1, and the dose-response analysis was conducted using STATA version 13 software.
Results
Among the 1,128 articles initially identified, 14 studies involving 12,887,398 subjects were included. Offspring exposed to maternal smoking during pregnancy exhibited an increased association with seizures (odds ratio 1.49, 95% confidence interval 1.21–1.84) compared to those whose mothers did not smoke during pregnancy. Subgroup analysis revealed a significantly heightened association in febrile convulsion, epilepsy, and neonatal seizure. Dose-response analysis shows a linear increase in childhood epilepsy with maternal smoking, where each additional daily cigarette raises the odds ratio by 1.7%.
Conclusions
Our study establishes a significant association between maternal smoking during pregnancy and seizures in offspring. These findings highlight the importance of public health efforts to reduce maternal smoking and highlight the potential impact on childhood health outcomes.
PROSPERO Registration number
CRD42023416464
Supplementary Information
The online version contains supplementary material available at 10.1186/s12884-026-08850-7.
Keywords: Maternal smoking, Pregnancy, Seizure, Systematic review, Meta-analysis
Introduction
Smoking is one of the well-known preventable unhealthy factors that have pulmonary and extrapulmonary effects [1]. According to the 2023 World Health Organization (WHO) reports, more than 8 million people die each year related to smoking, which includes 1.3 million non-smokers exposed to second-hand smoke [2]. Although the overall global trend of tobacco use is declining, the estimated prevalence of smokers is around 15.2% [3]. According to a recent meta-analysis, a significant association has been observed between current smokers and epilepsy, highlighting smoking as a potential risk factor [4].
Globally, the prevalence of current smoking among women is estimated at 17%, with higher rates reported in specific subgroups, including pregnant women, where the prevalence reaches 21% [5]. Maternal smoking during pregnancy has been mentioned as a risk factor for various diseases in offspring such as fetal growth retardation, obesity, and attention deficit hyperactivity disorder [6–8]. In addition, the brain structure and volume of offspring can be affected by maternal smoking during pregnancy [9, 10].
Seizures represent a transient occurrence of abnormal excessive or synchronous neuronal activity in the brain, manifesting with a variety of clinical symptoms ranging from brief lapses in attention to convulsions [11]. In pediatric populations, seizures are broadly categorized based on age of onset and underlying etiology, with febrile seizures, childhood epilepsy, and neonatal seizures being the most commonly studied subtypes [12]. Febrile seizures predominantly occur in children aged 6 months to 5 years, with recovery usually without long-term issues. Their prevalence ranges from 3.2 to 5.5 per 1,000 in developed countries to 3.6–44 per 1,000 in developing countries [13]. Childhood epilepsy, affecting about 58 per 100,000 children aged 1 to 10, arises from diverse causes including genetic mutations, chromosomal abnormalities, and environmental factors such as infections [14]. Neonatal seizures show a prevalence of 0.02% to 0.12%, varying by gestational age [15].
There have been efforts to demonstrate the associations between maternal smoking during pregnancy and childhood seizure. Several studies indicate a higher occurrence of seizures in children whose mothers smoked during pregnancy [16–19], while other research reports no notable variation in seizure frequency related to maternal smoking during pregnancy [20–22]. Although there are discrepancies in the findings of these related investigations, to date, no comprehensive literature review or meta-analysis has been undertaken. We aim to investigate the potential association between maternal smoking during pregnancy and the seizures in offspring.
Methods
Search strategy and eligibility criteria
The study protocol was registered with PROSPERO (registration number: CRD42023416464), and the methodology adhered to the PRISMA guidelines [23, 24]. A systematic literature search was conducted on May 12, 2025. To find studies of maternal smoking during pregnancy and seizure in offspring, we performed online searches of published literature using PubMed, Embase, ScienceDirect, Scopus, and Web of Science using the following terms: ‘smokers’, ‘smoking’, ‘tobacco’, ‘cigarette smoking’, ‘seizure’, ‘epilepsy’, ‘convulsion’, ‘pregnancy’, ‘maternal’, ‘mother’, ‘prenatal’, and ‘antenatal’. The specific search strategies were summarized in supplementary Table 1. The search was limited to titles and abstracts, and studies published in English and in any other language were considered eligible for inclusion. The language and publication year was not restricted. We manually searched the reference lists of the included studies.
We included cohort or case–control studies that presented results as unadjusted odds ratios (ORs) for seizures in offspring with or without maternal smoking during pregnancy. Even if the OR was not presented, the studies were included if the frequency of seizures in offspring according to maternal smoking during pregnancy was provided. The term “smoking during pregnancy” also encompasses cases where smoking occurred only during a part of the pregnancy period but does not include smoking only postnatally or when the mother smoked only pre-pregnancy. Studies without enough data were excluded. Papers using duplicate databases or not meeting the inclusion criteria were excluded, along with reviews, abstracts, and editorial materials.
Study selection and data extraction
Two authors (SY and KK) independently conducted the records search and screened the titles and abstracts of each study. The same authors then reviewed and evaluated the full-text articles for eligibility. During the study selection process, duplicate records were manually identified and removed. Any discrepancies were resolved through discussions among all authors. The final results were reached through consensus without any disagreements. During the screening phase, we extracted the following data: title, abstract, journal, author name, and year of publication. Further information on the number of cases with or without maternal smoking during pregnancy, the number of cases with or without seizures, the type of seizure, and the age of subjects was obtained through full-text evaluations.
Data analysis and synthesis
ORs and 95% confidence intervals (CIs) were extracted directly from papers. If the OR was not presented, it was calculated along with the 95% confidence intervals (CIs) based on the frequency of the 2 × 2 contingency Table [25]. We used the classification of I2 statistics to evaluate heterogeneity [26]. If the I2 value exceeded 50%, a random-effects model was applied, whereas for values below 50%, a fixed-effects model was applied [27]. The generic inverse variance method was used as a basic model for meta-analysis. Review Manager 5.4 software was used to synthesize the results. The exposure of interest was maternal smoking during pregnancy, which was defined as any smoking that occurred during any part of the pregnancy period. This definition excluded cases where smoking occurred only before pregnancy or only after delivery. The primary outcome of this study was the occurrence of seizures in offspring associated with maternal smoking during pregnancy, regardless of seizure subtype. Secondary outcomes included specific seizure subtypes—febrile convulsion, epilepsy/afebrile seizure, and neonatal seizure—as well as the dose-response relationship between the number of cigarettes smoked per day during pregnancy and seizure risk in offspring. To further explore potential sources of heterogeneity and assess the robustness of the findings, we conducted sensitivity analyses (including a leave-one-out method and exclusion of studies rated as ‘poor’ in quality) and stratified analyses by study design (cohort vs. case–control) and seizure subtype.
To conduct a dose-response examination of the relationship between smoking and the seizures in offspring, we employed restricted cubic spline analysis [28]. To construct a linear dose-response profile, relevant data on number of cigarettes per day, along with the number of cases and associated OR, were extracted from studies featuring a minimum of 3 quantitative exposure categories. A dose-response graph was generated using the STATA 13 software to visually represent the association.
Risk of bias assessment
The Newcastle-Ottawa Scale was utilized to assess the risk of bias [29]. Two authors (SY and KK) independently evaluated the included studies for the risk of bias, and any disagreements were resolved through discussion among all authors.
Publication bias
We created a funnel plot using Review Manager 5.4 software to visualize potential publication bias. Rank correlation and Egger’s regression test were utilized to quantitatively assess publication bias.
Certainty assessment
In this study, the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach was applied to determine how maternal smoking during pregnancy affects the occurrence of seizures in their offspring [30]. The body of evidence was classified as high, moderate, low, or very low based on five essential domains and two additional domains.
Results
Study selection and characteristics of the included studies
The search yielded 1024 articles. We then obtained 461 candidate articles for title and abstract review after excluding 667 non-human studies or non-articles. Forty-four articles underwent full-text review after excluding 417 duplicated or non-eligible articles based on their title and abstract. We conducted a full-text review of 44 articles, of which 30 were excluded due to reasons such as lack of reporting on the exposure or outcome of interest, irrelevant study population, or unmatched study design (Supplementary Table 2). In total, 14 studies were included in the meta-analysis, comprising eight cohort studies and six case–control studies [16–22, 31–37]. Finally, we obtained unadjusted estimates from studies for febrile convulsion (n = 6), epilepsy/unprovoked seizure (n = 4), and neonatal seizure (n = 2). Two studies included various types of seizures (Fig. 1).
Fig. 1.
Flow diagram illustrating the study selection process for the systematic review and meta-analysis
The included studies exhibited substantial variation in sample size, ranging from fewer than 200 participants in case–control studies to over 11 million individuals in large population-based cohorts. Maternal age was reported inconsistently, with some studies presenting categorical groups (< 20, 20–24, 25–29, 30–34, ≥ 35 years), while others reported mean values with standard deviations, typically between 25 and 29 years. Information on maternal comorbidities was also inconsistently reported. However, several studies provided data on conditions such as gestational diabetes, hypertension, preeclampsia, eclampsia, anticonvulsant use, and previous abortion. The characteristics of the included studies are summarized in Table 1.
Table 1.
Characteristics of the included studies (n = 14)
| Study design: Cohort study | ||||||
|---|---|---|---|---|---|---|
| Author (year) | No. of Total | Cohort data and study period |
Age of subject | Smoking category | Type of seizure (n) | Diagnostic criteria of seizure |
| Rantakallio et al. (1987) [21] | 3,664 | Live births in Northern Finland (1966) |
O: NA, 0–14 yrb M: NA |
Smokers / non-smokers | Epilepsy (n = 71) | At least one episode of paroxymal disturbances of consciousness, sensation, or movement |
| Nelson et al. (1990) [31] | 260,588a |
Collaborative Perinatal Project of the National Institute of Neurological Disorders and Stroke. (1983–1985) |
O: NA M: (No. of frequency(rate/10,000)) 10–14 year: (85) 15–19 year: (2,248) 20–24 year: (3,624) 25–29 year: (2,144) 30–34 year: (1,157) 35–49 year: (742) |
0/day 1–10/day 11–20/day 21–40/day 41–61/day |
FS (n = 9999) | An event in infancy or childhood, usually occurring between three months and five years of age, associated with fever but without evidence of intracranial infection or defined cause |
| Greenwood et al. (1998) [32] | 16,080 | British national cohort study (1970) |
O: NA, followed to age 10 yr M: (No. of frequency) < 20 year: (1579) 20–24 year: (5766) 25–29 year: (4973) 30–34 year: (2424) ≥ 35 year: (1322) |
Never Stopped pre pregnancy Stopped in pregnancy < 5/day 5–14/day + 15/day |
FS (n = 375) AFS (n = 63) |
Associated with fever but without evidence of intracranial infection or defined cause Idiopathic afebrile seizure was defined as a paroxysmal disturbance of consciousness, sensation, or movement, primarily cerebral in origin |
| Vahidnia et al. (2008) [33] | 10,108 | Child Health and Development Studies in the San Francisco-East, Bay Area (1959–1966) |
O: NA M: (mean age ± standard deviation) Non-smoker, non-alcohol drinker: 27 ± 6.1 yr Smoker, non-alcohol drinker: 25 ± 5.9 yr Non-smoker, alcohol drinker: 29 ± 5.6 yr Smoker, alcohol drinker: 28 ± 5.7 yr |
Smokers / non-smokers | FS (n = 209) | Convulsion occurred concurrently with a high fever and systemic infection |
| Nunes et al. (2011) [20] | 542 | Population based birth cohort study, Passo Fundo, Brazil |
O: followed to age 12 mo Epilepsy: 23 ± 12 mo FS, NS, AFS: NA M: NA |
Smokers / non-smokers |
FS (n = 27) NS (n = 10) Epilepsy (n = 11) AFS (n = 8) |
Epilepsy was defined as a condition characterized by recurrent unprovoked seizures A single unprovoked seizure or cluster of seizures occurring in a time interval below 24 h was considered a single seizure episode. |
| Mitsuda et al. (2019) [19] | 81,969 | Birth cohort study, Japan environmental and children’s study, 2011–2014 |
O: NA, followed to age 12 mo M: (No. of frequency) < 20 year: (578) 20–35 year: (60586) ≥ 35 year: (22914) |
Smokers / non-smokers | FS (n = 978) | C-1y questionnaire - diagnosed in their children when 12 months of age or younger. |
| Doty et al. (2020) [34] | 11,572,364 | United States vital statistics data sets on period linked birth–infant death, 2013–2017 |
O: Term infant (37–41 weeks of gestation) M: (No. of frequency) < 20 year: (832,694) 20–34 year: (93,52,352) ≥ 35 year: (1,551,104) |
Smokers / non-smokers | NS (n = 2834) | Any of the following: 5-minute Apgar score less than 5, assisted ventilation longer than 6 h, and neonatal mortality |
| Specht et al. (2020) [22] | 1,556 | Danish Civil Registration System, 1994–2002 |
O: followed to age 5yr M: Cases 28.7 ± 5.0 year, controls: 29.4 ± 4.7yr |
Smokers / non-smokers | Epilepsy (n = 403) | Epilepsy diagnosis (ICD-10 G40.9) occurring between 1 and 4 years of age. |
| Study design: Case–control study | ||||||
|---|---|---|---|---|---|---|
| Author (year) | No. of Total | Hospital or area | Age | Smoking | Type of seizure (n) | Diagnostic criteria of seizure |
| Cassano et al. (1990) [17] | 944 | Greater Seattle, Washington |
O: 8 ~ 34 mob M: cases 26.0 ± 5.0 year, controls 28.1 ± 4.6 yr |
Nonsmoker Quit smoking during pregnancy Smoked throughout pregnancy 1–10/day 11–20/day > 21/day |
FS (n = 472) | Febrile seizure was defined as complex if it lasted more than 15 min, had lateralized onset, or was followed by another febrile seizure within 24 h. Simple febrile seizures lacked all these characteristics. |
| Berg et al. (1995) [16] | 168 | Emergency departments of one of three hospitals in Bronx, New York. 1989–1992 |
O: cases 19.0 mo, control 19.3 mo M: NA |
None < 1/day 1–5/day 6–10/day 11–20/day > 20/day |
FS (n = 69) | Seizure with fever ≥ 101 °F and no history of previous febrile or unprovoked seizures |
| Sidenvall et al. (2001) [35] | 166 | Va¨sterbotten, northern Sweden in 1985 |
O: NA, 0–15 yrb M: Cases 28 year, controls: 27 yr |
Smokers / non-smokers | AFS (n = 58) | Unprovoked seizure if they occurred without an identifiable causative metabolic or an acute structural abnormality or occurred after the first week subsequent to an acute neurologic insult |
| Heydarian et al. (2018) [36] | 175 | Ghaem Hospital, Iran |
O: 23.0 ± 17.8 mo (6–60 mo) M: NA |
Smokers / non-smokers | FS (n = 97) | Not specified |
| Habbal et al. (2021) [37] | 334 | Three medical centers in Damascus, Syria. |
O: (No. of frequency) 28d–23 mo: (61) 2–11 year: (82) 12–18 year: (24) M: NA |
Smokers / non-smokers | Epilepsy (n = 167) | Simple febrile seizures are seizures which last from a few seconds to 15 min and do not recur during the same day while complex seizures last more than 15 min and may recur during 24 h |
| McLaren et al. (2022) [18] | 938,074 | United States Natality database from the National Center for Health Statistics in 2016–2018 |
O: Late preterm births neonate M: Cases 29 (24–34) yr, controls: 29 (24–34) yr |
Smokers / non-smokers | NS (n = 498) | United States Natality database |
AFS Afebrile seizure, FS Febrile seizure, M Maternal age, mo Months, NA Not available, NS Neonatal seizure, O Offspring’s age, yr Years
a. Total number of non-smoker and their seizure frequency were not directly described, so we indirectly calculated
b. If age of subject is not described, recruiting criteria of age was noted instead
Age was presented as mean ± standard deviation, median (interquartile range)
Overall seizure risk
Based on the results of 12,887,398 children reported in 14 observational studies, offspring with maternal smoking during pregnancy were at an elevated occurrence of seizures, with an OR of 1.49 (95% CI: 1.21–1.84, p < 0.001, I2 = 91%, p for heterogeneity < 0.001), compared with offspring whose mother did not smoke during pregnancy (Fig. 2). This result exhibited high heterogeneity among the included studies.
Fig. 2.
Forest plot illustrating the association between maternal smoking during pregnancy and the risk of seizures in offspring
Subgroup analysis
In subgroup analyses by type of seizure, in febrile convulsion, offspring exposed to maternal smoking during pregnancy had a higher occurrence of seizures, with an OR of 1.36 (95% CI: 1.09–1.70, p = 0.006, I2 = 79%, p for heterogeneity < 0.001) based on 371,496 children from 8 studies, indicating high heterogeneity among the included studies (Supplementary Fig. 1). In epilepsy and afebrile seizure, this trend persisted with an OR of 1.30 (95% CI: 1.06–1.59, p = 0.01, I2 = 13%, p for heterogeneity = 0.33) based on 21,986 children from 6 studies (Supplementary Fig. 2). In neonatal seizure, newborns similarly exposed were at an even greater risk with an OR of 2.01 (95% CI: 1.50–2.70, p < 0.001, I2 = 74%, p for heterogeneity = 0.02) based on 12,510,908 children from 3 studies (Supplementary Fig. 3). Both case-control study (OR 1.84, 95% CI: 1.66–2.03, p < 0.001, I2 = 11%, p for heterogeneity = 0.34) and cohort study (OR 1.32 95% CI: 1.04–1.67, p = 0.02, I2 = 90%, p for heterogeneity < 0.001) showed a significant association in subjects with maternal smoking during pregnancy (Supplementary Fig. 4, and 5).
Sensitivity analysis and Dose-response analysis
Leave-one-out sensitivity analysis confirmed the stability of the overall effect size, with no single study disproportionately influencing the results despite consistently high heterogeneity (Supplementary Fig. 6). Furthermore, we conducted an additional sensitivity analysis by excluding studies rated as ‘poor’ in quality. The pooled effect size remained significant, with an OR of 1.83 (95% CI: 1.36–2.43, p < 0.001; I²=27%, p for heterogeneity = 0.24) (Supplementary Fig. 7).
We conducted a dose-response analysis utilizing data from four studies (two cohort and two case-control) that included per-day information on smoking [16, 17, 31, 32]. Employing a restricted cubic splines model, we identified a linear increase between maternal smoking during pregnancy and the OR of offspring seizure (Fig. 3). The calculated regression coefficient was 1.017 (95% CI: 1.001–1.033, p = 0.04), suggesting that for each additional cigarette smoked per day, the OR increased by 1.7%. In practical terms, smoking 10 cigarettes per day during pregnancy was associated with an approximately 18% higher risk of seizures in offspring, while smoking 20 cigarettes per day was associated with about a 40% higher risk, compared with non-smokers.
Fig. 3.
Dose-response relationship between maternal smoking during pregnancy and the risk of childhood seizures, estimated using restricted cubic spline analysis (x-axis: maternal smoking per day; y-axis: odds ratio of childhood seizures)
Risk of bias within studies
The quality of the 14 included studies was found to be quite diverse (Supplementary Table 3). Out of these studies, four were rated as “good”, one as “fair”, and ten as “poor”.
Publication bias
The funnel plot for Fig. 4 shows no evidence of publication bias. Rank correlation yielded a p-value of 0.747, indicating no evidence of publication bias. Egger’s test for a regression intercept yielded a p-value of 0.076, indicating no evidence of publication bias.
Fig. 4.
Funnel plot assessing publication bias across 14 observational studies
Certainty assessment
According to the GRADE approach, the certainty of the evidence for the primary outcome was rated as low. The assessment was performed on eight domains, and the results are summarized in Table 2.
Table 2.
Grading of recommendations, assessment, development, and evaluations approach for the primary outcome
| Outcomes | Certainty assessment | Effect | Certainty | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Publication bias | Dose-response association | Residual confounding | OR (95% CI) | ||
| Maternal smoking - Pediatric seizure | 14 | Observational studiesa | Seriousb | Inconsistentc | Not seriousd | Not seriouse | Undetectedf | Present | Presentg | 1.49 (1.21–1.84) | Low |
CI Confidential interval, OR Odds ratio
aStudy design: All included studies are observational design
bRisk of bias: Serious concerns due to the observational design of all included studies and the majority being rated as low quality using the Newcastle-Ottawa Scale
cInconsistency: Serious inconsistency was observed with substantial heterogeneity (I² = 91%) and a significant p-value
dIndirectness: No serious indirectness as the PICO elements were well aligned with the research question
eImprecision: No serious imprecision as the pooled sample size was large and the confidence interval was narrow
fPublication bias: No strong evidence of publication bias according to Egger’s test (p = 0.076)
gResidual confounding is likely given the observational design and variability in adjusted covariates across studies
Discussion
This study presents the first systematic literature review and meta-analysis elucidating the correlation between maternal smoking during pregnancy and seizure occurrence in offspring. Previous studies have yielded inconsistent findings regarding this association, with some reporting an elevated risk while others observing no discernible relationship. Our findings indicate that offspring exposed to maternal smoking during pregnancy exhibit a 49% increased likelihood of developing seizures compared to those unexposed. Subgroup analyses based on epilepsy type revealed significant correlations across febrile convulsion, epilepsy/afebrile seizure, and neonatal seizure. Furthermore, subgroup analyses based on study design consistently demonstrated significant associations in cohort and case-control studies. This study could fill a crucial gap in the literature by synthesizing epidemiological research on the association between maternal smoking during pregnancy and childhood epilepsy.
There is experimental evidence supporting the association between smoking, the central nervous system, and seizures. Tobacco smoke contains a complex mixture of over 5,000 toxic chemicals, including nicotine [38]. Recent studies have unveiled the negative impacts of smoking on the central nervous system, highlighting its effects on brain development, function, and volume; neurotransmitter activity; cognition; neurovascular diseases; and oxidative stress [9, 39]. Notably, maternal smoking during pregnancy has been shown to influence the gene expression critically involved in neurodevelopment and fetal brain programming of their child [40]. Moreover, research on nicotine-induced seizures in mice has demonstrated that nicotine triggers convulsive seizures by activating neurons in the amygdala through nicotinic acetylcholine receptors [41].
In our study, substantial heterogeneity was observed, which may be attributed to differences in study design, population size, exposure definitions (e.g., timing and amount of maternal smoking), outcome classification (type of seizure), and inconsistent adjustment for confounders such as maternal age and family history of epilepsy. Despite these variations, our findings are consistent with previous studies indicating that maternal smoking during pregnancy is associated with adverse neurodevelopmental outcomes in offspring, including increased risks of attention deficit hyperactivity disorder (ADHD), cognitive impairment, and developmental coordination disorder [42–44]. In subgroup analysis, the ORs for neonatal seizure, febrile convulsion, and epilepsy/afebrile seizure were 2.01, 1.36, and 1.30, respectively. Although our study cannot explain why this difference in ORs exists according to seizure type, here are some speculative reasons for this difference. Firstly, the etiology of seizures differs among neonatal seizure, febrile convulsion, and epilepsy/afebrile [45, 46]. Second, the major causes of neonatal seizures, such as hypoxic-ischemic encephalopathy, ischemic stroke, and structural brain abnormalities, are among the factors associated with maternal smoking during pregnancy [9, 39, 45, 47, 48]. Third, epilepsy is a heterogeneous disorder with a wide range of age of onset, typically later than that of neonatal seizures and febrile convulsions [11]. The follow-up periods in the cohort studies may not be sufficient to confirm an association between epilepsy and maternal smoking during pregnancy.
In addition to assessing the overall association, we explored the dose-response relationship between maternal smoking during pregnancy and the risk of seizures in offspring. Using a restricted cubic spline model, we identified a linear trend indicating that seizure risk increases with the number of cigarettes smoked per day. Specifically, the odds ratio increased by approximately 1.7% for each additional cigarette smoked daily. This finding suggests a potential biological gradient, where higher levels of prenatal tobacco exposure may lead to a greater disruption of neurodevelopmental processes in the fetus. Such a dose-dependent relationship supports the plausibility of a causal link, in line with Bradford Hill’s criteria [49]. Previous studies have also reported dose-response associations between maternal smoking and adverse neurodevelopmental outcomes, including cognitive deficits, mood disorders, and attention disorders, which further corroborates our findings [50]. However, it is important to interpret these results with caution, as only a subset of included studies provided quantitative data on daily cigarette consumption. The limited number of studies and potential residual confounding factors, such as socioeconomic status and concurrent substance use, may influence the observed association. Despite these limitations, the dose-response analysis adds valuable evidence suggesting that even low levels of maternal smoking can contribute to seizure risk, emphasizing the importance of complete smoking cessation during pregnancy. Future large-scale prospective studies with detailed exposure assessment are warranted to further elucidate this relationship.
Our study has several limitations. Firstly, most of the included studies focused solely on maternal smoking during pregnancy, without considering exposure to passive environmental smoking or paternal smoking. Second, only three studies on neonatal seizures were included, which may be insufficient to conclusively determine that neonatal seizures are the most vulnerable to maternal smoking during pregnancy. Third, our results were not adjusted for potential confounding factors, such as family history of febrile seizures or epilepsy, and maternal age. Fourth, Substantial heterogeneity was observed, which may reflect differences in study design, population size, exposure definitions (timing and amount of maternal smoking), seizure classification, and adjustment for confounders. This heterogeneity suggests that the pooled estimate should be interpreted cautiously, as the true effect may vary across different settings. Despite these limitations, our study, complemented by prior observational and experimental studies, provides evidence that maternal smoking during pregnancy impacts seizure occurrence in offspring, as demonstrated through the first meta-analysis. Interestingly, while the extent of this impact varies, maternal smoking during pregnancy affects all three types of seizure disorders in offspring.
Conclusions
Based on a systematic review and meta-analysis of 14 observational studies, maternal smoking during pregnancy is associated with a 49% increased risk of seizures in offspring. According to the GRADE framework, the certainty of evidence for this association is rated as low, due to the observational design of included studies, serious risk of bias, and inconsistency among results. Accordingly, while our findings suggest a significant association, they should be interpreted with caution, and further high-quality prospective studies are needed to confirm this relationship. Nevertheless, considering the preventable nature of maternal smoking and its known adverse effects on fetal neurodevelopment, our findings support advising against smoking during pregnancy. These results should be communicated to healthcare providers and prospective parents to aid in smoking cessation efforts during pregnancy. In addition, healthcare providers may incorporate this evidence into prenatal counseling and design targeted smoking cessation programs to reduce preventable risks to child health.
Supplementary Information
Acknowledgements
None.
Abbreviations
- GRADE
Grading of Recommendations, Assessment, Development, and Evaluations
- OR
Odds ratio
- WHO
World Health Organization
Authors’ contributions
Author ContributionsSukdong Yoo: data curation, formal analysis, and writing – original draft preparation. Kihun Kim: data curation, formal analysis, and writing – original draft preparation. Eunjeong Son: methodology, software, supervision. Tae-Jin Song: validation, supervision Hyun-Woo Kim: validation, supervision. Kihyuk Shin: methodology, software, supervision. Dai Sik Ko: methodology, software, supervision. Su-Yeon Cho: methodology, software, supervision. Yujin Kwon: methodology, software, supervision. Won Kyu Kim: conceptualization, data curation, formal analysis, project administration, and writing – reviewing, and editing. Yun Hak Kim: conceptualization, data curation, formal analysis, funding acquisition, project administration, and writing – reviewing, and editing. All authors contributed to editing the manuscript. All authors have read and agreed to the published version of the manuscript.
Funding
This study was supported by the National Research Foundation of Korea (RS-2023-00223764), by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health &Welfare, Republic of Korea (RS-2025-02223691, RS-2025-25467811), by HRD Program for Industrial Innovation through the Korea Institute for Advancement Technology (KIAT) funded by the Ministry of Trade, Industry and Energy (RS-2025-02214034), and by a grant (RS-2024-00332024) from the Ministry of Food and Drug Safety, Republic of Korea. This work was supported by KREONET. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. RS-2024-00453708).
Data availability
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
Declarations
Ethics approval and consent to participate
This systematic review and meta-analysis used previously published data and did not require ethical approval, as it did not involve new data collection involving humans or animals.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Sukdong Yoo and Kihun Kim contributed equally to this work as first authors.
Contributor Information
Won Kyu Kim, Email: wkkim@kist.re.kr.
Yun Hak Kim, Email: yunhak10510@pusan.ac.kr.
References
- 1.Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007;131(5):1557–66. [DOI] [PubMed] [Google Scholar]
- 2.World Health Organization. WHO report on the global tobacco epidemic, 2023: protect people from tobacco smoke. 2023.
- 3.Peacock P A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905–26. [DOI] [PubMed] [Google Scholar]
- 4.Kang Y, Kim S, Jung Y, Ko DS, Kim H-W, Yoon J-P, et al. Exploring the Smoking-Epilepsy Nexus: a systematic review and meta-analysis of observational studies. BMC Med. 2024;22(1):1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Jafari A, Rajabi A, Gholian-Aval M, Peyman N, Mahdizadeh M, Tehrani H. National, regional, and global prevalence of cigarette smoking among women/females in the general population: a systematic review and meta-analysis. Environ Health Prev Med. 2021;26:1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Oken E, Levitan E, Gillman M. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes. 2008;32(2):201–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Abraham M, Alramadhan S, Iniguez C, Duijts L, Jaddoe VW, Den Dekker HT, et al. A systematic review of maternal smoking during pregnancy and fetal measurements with meta-analysis. PLoS ONE. 2017;12(2):e0170946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Langley K, Rice F, van den Bree MB, Thapar A. Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. Minerva Pediatr. 2005;57(6):359–71. [PubMed] [Google Scholar]
- 9.Bublitz MH, Stroud LR. Maternal smoking during pregnancy and offspring brain structure and function: review and agenda for future research. Nicotine Tob Res. 2012;14(4):388–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ekblad M, Korkeila J, Parkkola R, Lapinleimu H, Haataja L, Lehtonen L. Maternal smoking during pregnancy and regional brain volumes in preterm infants. J Pediatr. 2010;156(2):185–e190181. [DOI] [PubMed] [Google Scholar]
- 11.Fisher RS, Boas WVE, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46(4):470–2. [DOI] [PubMed] [Google Scholar]
- 12.Specchio N, Wirrell EC, Scheffer IE, Nabbout R, Riney K, Samia P, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63(6):1398–442. [DOI] [PubMed] [Google Scholar]
- 13.Camfield P, Camfield C. Incidence, prevalence and aetiology of seizures and epilepsy in children. Epileptic Disord. 2015;17(2):117–23. [DOI] [PubMed] [Google Scholar]
- 14.Aaberg KM, et al. "Incidence and prevalence of childhood epilepsy: a nationwide cohort study." Pediatrics. 2017;139(5):e20163908. [DOI] [PubMed]
- 15.Padiyar S, Nusairat L, Kadri A, Abu-Shaweesh J, Aly H. Neonatal seizures in the US National Inpatient Population: Prevalence and outcomes. Pediatr Neonatol. 2020;61(3):300–5. [DOI] [PubMed] [Google Scholar]
- 16.Berg AT, Shinnar S, Shapiro ED, Salomon ME, Crain EF, Hauser WA. Risk factors for a first febrile seizure: a matched case-control study. Epilepsia. 1995;36(4):334–41. [DOI] [PubMed] [Google Scholar]
- 17.Cassano PA, Koepsell TD, Farwell JR. Risk of febrile seizures in childhood in relation to prenatal maternal cigarette smoking and alcohol intake. Am J Epidemiol. 1990;132(3):462–73. discussion 474 – 468. [DOI] [PubMed] [Google Scholar]
- 18.McLaren R Jr., Clark M, Narayanamoorthy S, Rastogi S. Antenatal factors for neonatal seizures among late preterm births*. J Matern Fetal Neonatal Med. 2022;35(25):9544–8. [DOI] [PubMed] [Google Scholar]
- 19.Mitsuda N, Hosokawa T, Eitoku M, Fujieda M, Suganuma N. Breastfeeding and risk of febrile seizures in infants: The Japan Environment and Children’s Study. Brain Dev. 2019;41(10):839–47. [DOI] [PubMed] [Google Scholar]
- 20.Nunes ML, Geib LT. Incidence of epilepsy and seizure disorders in childhood and association with social determinants: a birth cohort study. J Pediatr (Rio J). 2011;87(1):50–6. [DOI] [PubMed] [Google Scholar]
- 21.Rantakallio P, Koiranen M. Neurological handicaps among children whose mothers smoked during pregnancy. Prev Med. 1987;16(5):597–606. [DOI] [PubMed] [Google Scholar]
- 22.Specht IO, Thorsteinsdottir F, Walker KC, Olsen J, Heitmann BL. Neonatal vitamin D status and risk of childhood epilepsy. Epilepsia. 2020;61(6):1282–90. [DOI] [PubMed] [Google Scholar]
- 23.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kim CM, Lee S, Hwang W, Son E, Kim TW, Kim K, et al. Obesity and periodontitis: A systematic review and updated meta-analysis. Front Endocrinol. 2022;13:999455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539–58. [DOI] [PubMed]
- 27.Yoon S, Kim K, Shin K, Kim HS, Kim B, Kim MB, et al. The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials. J Eur Acad Dermatol Venereol. 2024;38(1):52–61. [DOI] [PubMed] [Google Scholar]
- 28.Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175(1):66–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5. [DOI] [PubMed] [Google Scholar]
- 30.Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Nelson KB, Ellenberg JH. Prenatal and perinatal antecedents of febrile seizures. Ann Neurol 1990, 27(2):127–31. [DOI] [PubMed]
- 32.Greenwood R, Golding J, Ross E, Verity C. Prenatal and perinatal antecedents of febrile convulsions and afebrile seizures: data from a national cohort study. Paediatr Perinat Epidemiol. 1998;12(Suppl 1):76–95. [DOI] [PubMed] [Google Scholar]
- 33.Vahidnia F, Eskenazi B, Jewell N. Maternal smoking, alcohol drinking, and febrile convulsion. Seizure. 2008;17(4):320–6. [DOI] [PubMed] [Google Scholar]
- 34.Doty MS, Chen HY, Chauhan SP. Neonatal Seizures Among Low-Risk Pregnancies at Term: Risk Factors and Adverse Outcomes. Obstet Gynecol. 2020;135(6):1417–25. [DOI] [PubMed] [Google Scholar]
- 35.Sidenvall R, Heijbel J, Blomquist HK, Nyström L, Forsgren L. An incident case-control study of first unprovoked afebrile seizures in children: a population-based study of pre- and perinatal risk factors. Epilepsia. 2001;42(10):1261–5. [DOI] [PubMed] [Google Scholar]
- 36.Heydarian F, Bakhtiari E, Yousefi S, Heidarian M. The First Febrile Seizure: An Updated Study for Clinical Risk Factors. Inn J Pediatr. 2018;28(6):e69761.
- 37.Al Habbal A, AlSharif A, Almubark A, Fattouh H, Hamzeh G, Kakaje A. Risk factors associated with epilepsy in children and adolescents: A case-control study from Syria. Epilepsy Behav. 2021;114Pt A:107596. [DOI] [PubMed] [Google Scholar]
- 38.Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health. 2011;8(2):613–28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Hajdusianek W, et al. "Tobacco and nervous system development and function—new findings 2015–2020." Brain Sciences. 2021;11(6):797. [DOI] [PMC free article] [PubMed]
- 40.Salihu HM, Paothong A, Das R, King LM, Pradhan A, Riggs B et al. Evidence of altered brain regulatory gene expression in tobacco-exposed fetuses. J Perinat Med 2017, 45(9):1045–53. [DOI] [PubMed]
- 41.Iha HA, Kunisawa N, Shimizu S, Tokudome K, Mukai T, Kinboshi M et al. Nicotine Elicits Convulsive Seizures by Activating Amygdalar Neurons. Front Pharmacol 2017, 8:57. [DOI] [PMC free article] [PubMed]
- 42.Huang L, et al. "Maternal smoking and attention-deficit/hyperactivity disorder in offspring: a meta-analysis." Pediatrics. 2018;141(1):e20172465. [DOI] [PubMed]
- 43.Godleski S, Shisler S, Colton K, Leising M. Prenatal Tobacco Exposure and Behavioral Disorders in Children and Adolescents: Systematic Review and Meta-Analysis. Pediatr Rep. 2024;16(3):736–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Chen D, Niu Q, Liu S, Shao W, Huang Y, Xu Y, et al. The correlation between prenatal maternal active smoking and neurodevelopmental disorders in children: a systematic review and meta-analysis. BMC Public Health. 2023;23(1):611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Ziobro J, Shellhaas RA. Neonatal Seizures: Diagnosis, Etiologies, and Management. Semin Neurol. 2020;40(2):246–56. [DOI] [PubMed] [Google Scholar]
- 46.Kundu GK, Rabin F, Nandi E, Sheikh N, Akhter S. Etiology and risk factors of febrile seizure an update. Banglad J Child Health. 2010;34(3):103–12. [Google Scholar]
- 47.Barrois M, Patkai J, Delorme P, Chollat C, Goffinet F, Le Ray C. Factors associated with neonatal hypoxic ischemic encephalopathy in infants with an umbilical artery pH less than 7.00. Eur J Obstet Gynecol Reprod Biol. 2019;236:69–74. [DOI] [PubMed] [Google Scholar]
- 48.Darmency-Stamboul V, Chantegret C, Ferdynus C, Mejean N, Durand C, Sagot P, et al. Antenatal factors associated with perinatal arterial ischemic stroke. Stroke. 2012;43(9):2307–12. [DOI] [PubMed] [Google Scholar]
- 49.Hill AB. The environment and disease: association or causation? Sage; 1965.
- 50.Tiesler CM, Heinrich J. Prenatal nicotine exposure and child behavioural problems. Eur Child Adolesc Psychiatry. 2014;23:913–29. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data sharing is not applicable to this article as no new data were created or analyzed in this study.




